annual working capital:
$6.03B-$4.57B(-43.08%)Summary
- As of today (May 21, 2025), VRTX annual working capital is $6.03 billion, with the most recent change of -$4.57 billion (-43.08%) on December 31, 2024.
- During the last 3 years, VRTX annual working capital has fallen by -$1.39 billion (-18.69%).
- VRTX annual working capital is now -43.08% below its all-time high of $10.60 billion, reached on December 31, 2023.
Performance
VRTX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$6.23B+$193.80M(+3.21%)Summary
- As of today (May 21, 2025), VRTX quarterly working capital is $6.23 billion, with the most recent change of +$193.80 million (+3.21%) on March 31, 2025.
- Over the past year, VRTX quarterly working capital has dropped by -$3.27 billion (-34.42%).
- VRTX quarterly working capital is now -43.90% below its all-time high of $11.10 billion, reached on September 30, 2023.
Performance
VRTX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
VRTX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.1% | -34.4% |
| 3 y3 years | -18.7% | -23.9% |
| 5 y5 years | +72.9% | +59.3% |
VRTX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.1% | at low | -43.9% | +15.4% |
| 5 y | 5-year | -43.1% | +72.9% | -43.9% | +59.3% |
| alltime | all time | -43.1% | >+9999.0% | -43.9% | >+9999.0% |
VRTX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $6.23B(+3.2%) |
| Dec 2024 | $6.03B(-43.1%) | $6.03B(+3.4%) |
| Sep 2024 | - | $5.83B(+8.1%) |
| Jun 2024 | - | $5.39B(-43.2%) |
| Mar 2024 | - | $9.49B(-10.4%) |
| Dec 2023 | $10.60B(+1.0%) | $10.60B(-4.5%) |
| Sep 2023 | - | $11.10B(+5.5%) |
| Jun 2023 | - | $10.52B(+5.8%) |
| Mar 2023 | - | $9.94B(-5.3%) |
| Dec 2022 | $10.49B(+41.4%) | $10.49B(+8.6%) |
| Sep 2022 | - | $9.66B(+8.0%) |
| Jun 2022 | - | $8.95B(+9.4%) |
| Mar 2022 | - | $8.18B(+10.3%) |
| Dec 2021 | $7.42B(+18.6%) | $7.42B(+6.9%) |
| Sep 2021 | - | $6.94B(+4.8%) |
| Jun 2021 | - | $6.62B(+0.4%) |
| Mar 2021 | - | $6.60B(+5.4%) |
| Dec 2020 | $6.26B(+79.4%) | $6.26B(+14.7%) |
| Sep 2020 | - | $5.45B(+11.4%) |
| Jun 2020 | - | $4.90B(+25.3%) |
| Mar 2020 | - | $3.91B(+12.0%) |
| Dec 2019 | $3.49B(+28.1%) | $3.49B(+2.9%) |
| Sep 2019 | - | $3.39B(-1.8%) |
| Jun 2019 | - | $3.45B(+12.2%) |
| Mar 2019 | - | $3.08B(+13.0%) |
| Dec 2018 | $2.72B(+47.8%) | $2.72B(+1.1%) |
| Sep 2018 | - | $2.69B(+8.6%) |
| Jun 2018 | - | $2.48B(+12.0%) |
| Mar 2018 | - | $2.21B(+20.2%) |
| Dec 2017 | $1.84B(+77.3%) | $1.84B(+13.9%) |
| Sep 2017 | - | $1.62B(+4.0%) |
| Jun 2017 | - | $1.56B(+12.5%) |
| Mar 2017 | - | $1.38B(+33.0%) |
| Dec 2016 | $1.04B(+15.3%) | $1.04B(+33.4%) |
| Sep 2016 | - | $779.06M(-6.3%) |
| Jun 2016 | - | $831.29M(-2.3%) |
| Mar 2016 | - | $850.79M(-5.6%) |
| Dec 2015 | $900.99M(-23.5%) | $900.99M(-8.5%) |
| Sep 2015 | - | $984.49M(+6.9%) |
| Jun 2015 | - | $920.87M(-12.8%) |
| Mar 2015 | - | $1.06B(-10.4%) |
| Dec 2014 | $1.18B(-1.0%) | $1.18B(-7.8%) |
| Sep 2014 | - | $1.28B(+29.8%) |
| Jun 2014 | - | $984.41M(-6.9%) |
| Mar 2014 | - | $1.06B(-11.2%) |
| Dec 2013 | $1.19B(+2.9%) | $1.19B(-3.9%) |
| Sep 2013 | - | $1.24B(-7.2%) |
| Jun 2013 | - | $1.33B(+15.3%) |
| Mar 2013 | - | $1.16B(+0.1%) |
| Dec 2012 | $1.16B(+23.2%) | $1.16B(-5.8%) |
| Sep 2012 | - | $1.23B(+1.2%) |
| Jun 2012 | - | $1.21B(+12.4%) |
| Mar 2012 | - | $1.08B(+15.0%) |
| Dec 2011 | $938.91M(+61.3%) | $938.91M(+34.7%) |
| Sep 2011 | - | $696.88M(+100.2%) |
| Jun 2011 | - | $348.16M(-23.8%) |
| Mar 2011 | - | $456.78M(-21.6%) |
| Dec 2010 | $582.26M(-43.0%) | $582.26M(-36.4%) |
| Sep 2010 | - | $914.87M(+28.5%) |
| Jun 2010 | - | $712.18M(-22.2%) |
| Mar 2010 | - | $915.23M(-10.5%) |
| Dec 2009 | $1.02B(+57.0%) | $1.02B(+49.7%) |
| Sep 2009 | - | $682.70M(+14.0%) |
| Jun 2009 | - | $599.08M(-17.1%) |
| Mar 2009 | - | $722.87M(+11.0%) |
| Dec 2008 | $651.02M | $651.02M(-15.7%) |
| Sep 2008 | - | $772.55M(+14.5%) |
| Jun 2008 | - | $674.73M(+10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $610.62M(+105.2%) |
| Dec 2007 | $297.57M(-42.8%) | $297.57M(-16.8%) |
| Sep 2007 | - | $357.57M(-17.8%) |
| Jun 2007 | - | $434.75M(-18.3%) |
| Mar 2007 | - | $531.95M(+2.2%) |
| Dec 2006 | $520.39M(+82.7%) | $520.39M(-10.5%) |
| Sep 2006 | - | $581.25M(+69.0%) |
| Jun 2006 | - | $343.85M(+19.5%) |
| Mar 2006 | - | $287.81M(+1.1%) |
| Dec 2005 | $284.81M(+15.4%) | $284.81M(-5.9%) |
| Sep 2005 | - | $302.52M(-7.6%) |
| Jun 2005 | - | $327.32M(+62.2%) |
| Mar 2005 | - | $201.86M(-18.2%) |
| Dec 2004 | $246.89M(-45.7%) | $246.89M(-17.3%) |
| Sep 2004 | - | $298.39M(-11.4%) |
| Jun 2004 | - | $336.76M(-18.4%) |
| Mar 2004 | - | $412.60M(-9.3%) |
| Dec 2003 | $454.74M(-23.2%) | $454.74M(-7.3%) |
| Sep 2003 | - | $490.45M(-12.8%) |
| Jun 2003 | - | $562.72M(-12.3%) |
| Mar 2003 | - | $641.68M(+8.4%) |
| Dec 2002 | $591.98M(-13.5%) | $591.98M(-3.7%) |
| Sep 2002 | - | $614.87M(-4.7%) |
| Jun 2002 | - | $645.32M(-2.0%) |
| Mar 2002 | - | $658.24M(-3.8%) |
| Dec 2001 | $684.54M(+57.9%) | $684.54M(+103.4%) |
| Sep 2001 | - | $336.52M(+15.4%) |
| Jun 2001 | - | $291.62M(-3.2%) |
| Mar 2001 | - | $301.41M(-30.5%) |
| Dec 2000 | $433.44M(+145.3%) | $433.44M(-17.0%) |
| Sep 2000 | - | $522.35M(+44.7%) |
| Jun 2000 | - | $360.93M(+6.9%) |
| Mar 2000 | - | $337.71M(+91.1%) |
| Dec 1999 | $176.68M(-25.0%) | $176.68M(-2.4%) |
| Sep 1999 | - | $181.00M(-8.2%) |
| Jun 1999 | - | $197.10M(-7.4%) |
| Mar 1999 | - | $212.90M(-9.6%) |
| Dec 1998 | $235.60M(-12.1%) | $235.60M(-5.6%) |
| Sep 1998 | - | $249.70M(+0.2%) |
| Jun 1998 | - | $249.20M(-3.7%) |
| Mar 1998 | - | $258.80M(-3.4%) |
| Dec 1997 | $267.90M(+114.1%) | $267.90M(-2.1%) |
| Sep 1997 | - | $273.70M(-1.7%) |
| Jun 1997 | - | $278.50M(+4.0%) |
| Mar 1997 | - | $267.70M(+114.0%) |
| Dec 1996 | $125.10M(+58.2%) | $125.10M(-1.5%) |
| Sep 1996 | - | $127.00M(+132.2%) |
| Jun 1996 | - | $54.70M(-23.1%) |
| Mar 1996 | - | $71.10M(-10.1%) |
| Dec 1995 | $79.10M(-21.6%) | $79.10M(-1.0%) |
| Sep 1995 | - | $79.90M(-7.6%) |
| Jun 1995 | - | $86.50M(-8.7%) |
| Mar 1995 | - | $94.70M(-6.1%) |
| Dec 1994 | $100.90M(+120.3%) | $100.90M(+12.5%) |
| Sep 1994 | - | $89.70M(-5.6%) |
| Jun 1994 | - | $95.00M(-5.2%) |
| Mar 1994 | - | $100.20M(+118.8%) |
| Dec 1993 | $45.80M(+14.2%) | $45.80M(+24.8%) |
| Sep 1993 | - | $36.70M(-6.1%) |
| Jun 1993 | - | $39.10M(+8.6%) |
| Mar 1993 | - | $36.00M(-10.2%) |
| Dec 1992 | $40.10M(-18.2%) | $40.10M(-8.0%) |
| Sep 1992 | - | $43.60M(-3.5%) |
| Jun 1992 | - | $45.20M(-3.0%) |
| Mar 1992 | - | $46.60M(-4.9%) |
| Dec 1991 | $49.00M(+1533.3%) | $49.00M(+95.2%) |
| Sep 1991 | - | $25.10M(+8266.7%) |
| Jun 1991 | - | $300.00K(-90.0%) |
| Dec 1990 | $3.00M | $3.00M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual working capital?
- What is the all time high annual working capital for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual working capital year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly working capital?
- What is the all time high quarterly working capital for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly working capital year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual working capital?
The current annual working capital of VRTX is $6.03B
What is the all time high annual working capital for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual working capital is $10.60B
What is Vertex Pharmaceuticals Incorporated annual working capital year-on-year change?
Over the past year, VRTX annual working capital has changed by -$4.57B (-43.08%)
What is Vertex Pharmaceuticals Incorporated quarterly working capital?
The current quarterly working capital of VRTX is $6.23B
What is the all time high quarterly working capital for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly working capital is $11.10B
What is Vertex Pharmaceuticals Incorporated quarterly working capital year-on-year change?
Over the past year, VRTX quarterly working capital has changed by -$3.27B (-34.42%)